FDA approves once-daily ruxolitinib XR for MF, PV and GVHD, offering simplified dosing with comparable drug exposure to twice ...

Datopotamab deruxtecan (Datroway) demonstrated improved progression-free survival (PFS) and overall survival (OS) compared ...

Oncology nurses play a critical role in the success of clinical trials, balancing patient care, safety and research ...

FDA approves vepdegestrant for ER-positive, HER2-negative breast cancer. Learn key efficacy data, safety risks, and nursing ...

In bladder cancer care, nurses play a critical and continuous role throughout a patient’s journey, especially during ...

Oncology nurse practitioners discuss CD38-based frontline therapy for newly diagnosed multiple myeloma, including Dara-VRd ...

Paget disease of the breast: key signs, diagnosis, and treatment strategies oncology nurses should know to support early ...

When we think about cancer and treatment, we often picture older patients who have lived many years and now face a new ...

Phase 3 MagnetisMM-5 trial data in multiple myeloma highlight progression-free survival gains and key safety considerations ...

Workforce shortages, delayed diagnoses, and systemic barriers continue to limit cancer care delivery in low-resource settings ...

Dr. Azmi emphasized that oncology nurses are often on the front lines of patient education and can play a critical role in ...